Pernix Therapeutics

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and
commercializing prescription drugs primarily for the U.S. market. The Company targets underserved
therapeutic areas such as CNS, including neurology and pain management, and has an interest in
expanding into additional specialty segments. Pernix promotes its branded products to physicians
through its two sales forces and markets its generic portfolio through its wholly owned subsidiaries,
Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.